News Items 2022
EMERG members have collaborated in HPV research and the following paper has now been published -
Autoimmunity in patients reporting long-term complications after exposure
to human papilloma virus vaccination
Several EMERG researchers were involved in this paper - including EMERG co-chair Dr Jesper Mehlsen.
EMERG member Anders Rosén was a participant in the recently published paper -
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is
unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
In June 2021 at UK charity Invest in ME Research's tenth annual International Biomedical Research into ME Colloquium
(#BRMEC10) ME researchers from around the world met up to discuss research, both past and current,
The agenda was created with the help of The European ME Research Group
and was developed to test popular hypotheses that explain the aetiology of ME.
These included: immunogenetics and dysfunctional immune responses; an abnormal autonomous nervous system
and autoimmunity; mitochondrial metabolic dysfunction; and altered host-microbe (commensal and pathogen)
interactions.
A paper has been published that summarises discussions in one of the hypotheses from one of the Colloquium
sessions - that immune dysfunction and viral factors may drive the development and progression of ME.
EMERG member Hanna Ollila has been granted an award from the Academy of Finland for research into ME.
This was one of 22 new Academy Research Fellows selected in biosciences, health and environmental research.
The selections emphasised the high scientific quality of the projects and international research cooperation.
EMERG will again play a major role in the annual international research Colloquium organised by UK charity
Invest in ME Research. This year will be the 11th Colloquium - #BRMEC11.
EMERG will be chairing sessions in the Colloquium.